Virtu Financial’s Definium Therapeutics DFTX Stock Holding History

Virtu Financial’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,460	Closed	-$273K	–	1992
2026 Q1	$273K	Buy	+14,460	New	+$245K	0.01%	861
2025 Q4	–	Sell	-32,184	Closed	-$379K	–	2015
2025 Q3	$379K	Buy	+32,184	New	+$300K	0.02%	661
2025 Q2	–	Sell	-32,836	Closed	-$192K	–	1817
2025 Q1	$192K	Buy	+32,836	New	+$235K	0.01%	825
2024 Q2	–	Sell	-25,440	Closed	-$239K	–	1669
2024 Q1	$239K	Buy	+25,440	New	+$145K	0.02%	706
2023 Q4	–	Sell	-28,494	Closed	-$89K	–	1846
2023 Q3	$89K	Buy	+28,494	New	+$117K	0.01%	843
2023 Q1	–	Sell	-70,157	Closed	-$154K	–	1854
2022 Q4	$154K	Buy	70,157 +34,247	+95%	+$95.1K	0.02%	805
2022 Q3	$126K	Buy	+35,910	New	+$345K	0.01%	1024
2022 Q2	–	Sell	-1,736	Closed	-$29K	–	1880
2022 Q1	$29K	Buy	+1,736	New	+$30.1K	﹤0.01%	1243
2021 Q4	–	Sell	-2,490	Closed	-$87K	–	2000
2021 Q3	$87K	Sell	2,490 -13,037	-84%	-$564K	0.01%	1181
2021 Q2	$804K	Buy	+15,527	New	+$815K	0.08%	281

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Virtu Financial's DFTX Position: Q2 2026 in Review

Virtu Financial sold out of Definium Therapeutics (DFTX) in Q2 2026, closing a stake of 14,460 shares — an estimated $273K sold.

Virtu Financial first reported a position in DFTX in Q2 2021 and held it in 10 quarters. The position peaked at $804K in Q2 2021. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Virtu Financial reported no remaining Definium Therapeutics position as of Q2 2026 after selling out during the quarter.
Virtu Financial sold 14,460 Definium Therapeutics shares in Q2 2026, an estimated $273K.
Virtu Financial first reported a position in Definium Therapeutics in Q2 2021 and held it in 10 quarters.
Virtu Financial's Definium Therapeutics position peaked at $804K in Q2 2021.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.